Tag: Biotech
Acticor Biotech raises 8 million euros for its stroke treatment – 03/15/2024 at 09:46
(AOF) – Acticor Biotech announces the success of its capital increase for a total gross amount of 8 million euros, through the issue of 2.56 million new shares at a…
AstraZeneca buys French biotech Amolyt Pharma for near-record sum of $1 billion
In the history of French biotech, Amolyt Pharma will undoubtedly feature prominently in the pantheon of French successes. The company, based in Ecully, in the Lyon metropolis, has just announced,…
Acticor Biotech launches a capital increase of at least €7 million – 03/14/2024 at 6:15 p.m.
• Capital increase consisting of an offer to qualified investors, categories of investors, as well as individual investors via the PrimaryBid platform• Subscription commitments from historic shareholders and new investors…
BeiGene, the biotech from China that wants to break the codes
Vice President of BeiGene Dr. Du Zhengming introduces the company to foreign reporters in Suzhou, Jiangsu province, China, 5 January 2020. GABRIEL GAUFFRE / XINHUA NEWS AGENCY BeiGene doesn’t like…
The hunt for capital, the eternal anguish of biotech
The French exception did not last. Whereas a year earlier the healthtech sector – which today brings together 2,660 companies, including 820 biotechs, 1,393 medtechs (manufacturers of medical devices) and…
AstraZeneca buys American biotech Icosavax, vaccine specialist
(AOF) – AstraZeneca today announced the successful completion of the acquisition of Icosavax, a US clinical-stage biopharmaceutical company focused on the development of high-potential differentiated vaccines using an innovative virus-like…
Sartorius Stedim Biotech announces a dividend of 0.69 euros per share
(AOF) – Sartorius Stedim Biotech announces that during its meeting today, the board of directors decided to propose to the combined annual general meeting of shareholders, scheduled for March 26,…
Sartorius Stedim Biotech launches an offering of new shares for 1.2 billion euros
(AOF) – Sartorius Stedim Biotech announces the launch of an offering of new shares for an amount of approximately 1.2 billion euros, with elimination of shareholders’ preferential subscription rights through…
Acticor biotech: ‘we are pleased to observe the market reaction’
Read also (CercleFinance.com) – The French biopharmaceutical company Acticor Biotech found itself in the spotlight last week after the success of a clinical trial in the emergency treatment of stroke.…
Acticor biotech: The surge continues, hopes in strokes
Read also (CercleFinance.com) – Acticor Biotech shares continued to soar on the Paris Stock Exchange on Wednesday, the day after the biopharmaceutical company presented positive results in strokes. At 4:30…
Biotech is struggling to emerge from its lethargy
In a production laboratory of Takeda Pharmaceutical Belgium, in Lessines, February 28, 2023. LAURIE DIEFFEMBACQ / AFP Is this the start of the thaw? In the aisles of the forty-second…
Sartorius Stedim Biotech: the right price?
By Hector Chaunu Published on 06/12/2023 at 10:35 a.m. Sartorius Stedim Biotech regains 0.9% this Wednesday, to 198.50 euros, while JP Morgan remains ‘overweight’…